Read all posts

CardioBreak: Blood Thinners, Fish Oil on Trial

How do the available blood thinners compare head-to-head for acute venous thromboembolism? A study in JAMA outlined a few differences. Even though the FDA rejected an expanded indication for prescription EPA-only fish oil, icosapent ethyl (Vascepa), drugmaker Amarin announced it would finish the REDUCE-IT cardiovascular outcomes trial.

Read the article on Medpagetoday

Dr. Sears Comments:

Dr. Barry Sears

The published data are clear that even high-dose fish oil doesn’t cause increased bleeding if the AA/EPA ratio remains above 1. Relative to the declining rate of CHD mortality in the last 30 years, give the credit to reduced smoking, not increased statins.

Leave a Reply

Your email address will not be published. Required fields are marked *